It was something of an up-and-down week for IPOs: Two biotechs, Alzheimer’s focused Alzheon and brittle bone drug company Mereo BioPharma pulled their ...
Noting that General Electric had an awful year in 2017, losing 44.8 percent of its stock value, Boston Business Journal took a look at the state’s biggest stock losers.